Clinical trial
Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines
NCT00008853 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00008853 |
|---|---|
| Title | Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines |
| Official title | Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bacterial Infections, Group B Streptococcus |
| Intervention type | Biological |
| Interventions | GBS III-TT-SSI, GBS III-TT-MPHL |
| Enrollment | 65 |
| Completion | Nov 1, 2005 |
| First posted | Aug 31, 2001 |
| Last update posted | Aug 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: